Root Financial Partners
ELDN icon

Root Financial Partners’s Eledon Pharmaceuticals ELDN Stock Holding History

Root Financial Partners’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$281 Buy
+111
New +$373 ﹤0.01% 3419
2026
Q2 		– Sell
-110
Closed -$339 – 1224
2026
Q1 		$339 Buy
+110
New +$259 ﹤0.01% 2988

Other funds holding ELDN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Triumph Capital Management
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Daytona Street Capital
Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return
Prodigy Asset Management
Prodigy Asset Management Omaha, Nebraska $335M AUM 5.94% 1-Year Est. Return
Farmers & Merchants Investments Inc
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.16B AUM 24.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Root Financial Partners's ELDN Position: Q3 2026 in Review

Root Financial Partners opened a new position in Eledon Pharmaceuticals (ELDN) in Q3 2026: 111 shares worth $281. The stake represents ﹤0.01% of the portfolio and ranks #3419 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in ELDN as recently as Q1 2026.

Root Financial Partners first reported a position in ELDN in Q1 2026 and has held it in 2 quarters since. The position peaked at $339 in Q1 2026. 65 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • Root Financial Partners held 111 shares of Eledon Pharmaceuticals worth $281 as of Q3 2026.
  • Eledon Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3419 holding.
  • Root Financial Partners first reported a position in Eledon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Root Financial Partners's Eledon Pharmaceuticals position peaked at $339 in Q1 2026.
  • 65 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.